Self-hypnosis training for managing chronic pain
Official title: Self-hypnosis Training in Chronic Pain Management: A Qualitative Exploratory Study of Patients Practicing Self-hypnosis
Run by Ciusss de L'Est de l'Île de Montréal · NCT06279650 · Data updated 2026-11-12
This study is testing a self-hypnosis training program to see if it can help people with chronic pain feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ciusss de L'Est de l'Île de Montréal Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | June 2025 |
| Study ends | December 2025 |
| Registry record updated | January 28, 2025 |
| Trial ID | NCT06279650 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have chronic pain lasting at least 3 months and can participate in a telepractice intervention.
✕Probably not a fit
Patients with severe cognitive impairments or current psychiatric instability may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the effectiveness of a self-hypnosis training program designed for chronic pain management. Participants will engage in self-hypnosis practices within groups, with the primary focus on assessing changes in pain levels over a 3-month and 6-month follow-up period. Secondary objectives include measuring the impact of the intervention on functional pain effects, anxiety-depression scores, and overall quality of life. The study will involve 60 patients from pain clinics and will be conducted at the Centre de Recherche de l'Hôpital Maisonneuve-Rosemont in Montreal, Quebec.
Why it matters
Potential benefit: If successful, this approach could significantly reduce chronic pain and improve the quality of life for patients.
How similar studies have gone: While self-hypnosis has been explored in other contexts, this specific application for chronic pain management is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews. * be 18 years of age or older; * have received one of the above diagnoses, confirmed by medical record review or physician confirmation; * report pain that has been present for at least 3 months; * have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline; * be able to read, speak and understand French; * have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires. Exclusion Criteria: * have deafness and/or severe cognitive impairment that may impair communication; * have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
Where it's running
-
5415 Bd de l'Assomption
Montreal, Quebec, Canada Recruiting
Study contacts
- Study coordinator: David Ogez
- Email: david.ogez@umontreal.ca
- Phone: 514 609-4391
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile app delivering pain education and clinical hypnosis for chronic low back pain
This study will test whether a mobile app that provides pain education and clinical hypnosis can reduce pain and disability in people with non-specific chronic low back pain who are seeing a GP in Australia.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Higher-dose UM171 to improve cord blood stem cell transplants
This will try a higher lab dose of UM171 to expand umbilical cord blood stem cells for adults with high-risk leukemia or myelodysplasia who lack a suitable donor to see if they recover blood counts faster and have fewer complications after transplant.
-
Home-based transcranial direct current stimulation (tDCS) for depression in borderline personality disorder
This project will see if 14 home-based tDCS sessions, compared with sham, can reduce depressive symptoms in adults with borderline personality disorder and moderate-to-severe depression.
-
Dexmedetomidine infusion to reduce intraoperative remifentanil use during laparoscopic abdominal surgery
This trial tests whether giving a dexmedetomidine infusion during laparoscopic abdominal surgery can lower the amount of remifentanil needed during the operation.
-
Quality of life during the transition to home versus in-center dialysis
This project will see if people with advanced CKD who start home dialysis have better quality of life and less frailty over the first year than those who start in-center hemodialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.